Health Canada
Symbol of the Government of Canada

Common menu bar links

Health Concerns

Canadian Alcohol and Drug Use Monitoring Survey


Table 1: Main 2011 CADUMS indicators by sex and by age - Drugs
 
Overall
Males
Females
15-24
25+

[95% Confidence Interval]

  •  Sample size
  •  Estimate suppressed due to high sampling variability
  •  Estimate qualified due to high sampling variability; interpret with caution
  •  Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  •  Cocaine/crack, speed, ecstasy, hallucinogens, heroin
  •  Cannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high

Table 1 footnotes

Table 1 footnote 1

Significant difference between males and females *p<.05

Return to table 1 footnote 1 referrer

Table 1 footnote 2

Significant difference between youth age 15-24 and adults age 25+, *p<.05

Return to table 1 footnote 2 referrer

Table 1 footnote 3

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 1 footnote 3 referrer

Table 1 footnote 4

Among current user any 5 drugs (cocaine, speed, hallucinogens including salvia, ecstasy, heroin)

Return to table 1 footnote 4 referrer

Table 1 footnote 5

Among current users any drug (cannabis, cocaine, meth/crystal meth, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, abuse of pain killers, abuse of stimulants, sedatives to get high)

Return to table 1 footnote 5 referrer

Sample size= 10,076 4,247 5,829   671 9,405  
Cannabis use
Cannabis - lifetime 39.4
[37.6-41.8]
45.5
[42.7-48.3]
33.6
[31.3-35.9]
Significant difference between males and females *p<.05 34.0
[28.5-39.5]
40.4
[38.6-42.3]
Significant difference between youth age 15-24 and adults age 25+, *p<..05
Cannabis - past-year 9.1
[8.0-10.2]
12.2
[10.4-14.0]
6.2
[5.0-7.4]
Significant difference between males and females *p<.05 21.6
[16.9-26.3]
6.7
[5.8-7.6]
Significant difference between youth age 15-24 and adults age 25+, *p<..05
Age of initiation (years) 18.8
[18.5-19.1]
18.6
[18.2-19.0]
19.0
[18.6-19.4]
  15.6
[15.3-15.9]
19.3
[19.0-19.6]
Significant difference between youth age 15-24 and adults age 25+, *p<..05
Illicit drug use past year
Cocaine/Crack 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.3]
1.4Estimate qualified due to high sampling variability; interpret with caution
[0.7-2.2]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.0]
 
Speed 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Methamphetamine/Crystal meth Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Hallucinogens 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.4]
Estimate suppressed due to high sampling variability   2.0Estimate qualified due to high sampling variability; interpret with caution
[0.8-3.1]
Estimate suppressed due to high sampling variability  
Hallucinogens (including salvia) 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.2]
1.3Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.9]
Estimate suppressed due to high sampling variability   3.4Estimate qualified due to high sampling variability; interpret with caution
[1.5-5.2]
Estimate suppressed due to high sampling variability  
Ecstasy 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.0]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.3]
Estimate suppressed due to high sampling variability   2.6Estimate qualified due to high sampling variability; interpret with caution
[1.1-4.1]
Estimate suppressed due to high sampling variability  
Salvia Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Heroin Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 9.4
[8.3-10.5]
12.4
[10.6-14.3]
6.5
[5.2-7.7]
Significant difference between males and females *p<.05 21.9
[17.2-26.6]
6.9
[6.0-7.9]
Significant difference between males and females *p<.05
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 1.7
[1.2-2.2]
2.4Estimate qualified due to high sampling variability; interpret with caution
[1.5-3.3]
1.0Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.5]
Significant difference between males and females *p<.05 4.8Estimate qualified due to high sampling variability; interpret with caution
[2.5-7.2]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.5]
Significant difference between males and females *p<.05
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 9.4
[8.3-10.5]
12.5
[10.6-14.3]
6.5
[5.2-7.7]
Significant difference between males and females *p<.05 21.9
[17.2-26.6]
6.9
[6.0-7.9]
Significant difference between males and females *p<.05
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 1.9
[1.3-2.4]
2.7Estimate qualified due to high sampling variability; interpret with caution
[1.7-3.7]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.6]
Significant difference between males and females *p<.05 5.8Estimate qualified due to high sampling variability; interpret with caution
[3.2-8.5]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.5]
Significant difference between males and females *p<.05
Any drugCannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high 9.9
[8.7-11.0]
13.0
[11.1-14.9]
6.9
[5.6-8.2]
Significant difference between males and females *p<.05 23.1
[18.2-28.0]
7.3
[6.4-8.3]
Significant difference between males and females *p<.05
Lifetime Illicit drug use
Cocaine/Crack 6.2
[5.4-7.2]
8.5
[7.0-10.0]
4.2
[3.3-5.1]
Significant difference between males and females *p<.05 4.8Estimate qualified due to high sampling variability; interpret with caution
[2.1-7.4]
6.6
[5.7-7.5]
 
Speed 3.4
[2.8-4.1]
4.5
[3.5-5.6]
2.4
[1.8-3.1]
Significant difference between males and females *p<.05 4.0Estimate qualified due to high sampling variability; interpret with caution
[2.0-6.1]
3.4
[2.7-4.0]
 
Methamphetamine/Crystal meth 0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.6]
 
Hallucinogens 10.4
[9.4-11.5]
13.6
[11.9-15.3]
7.4
[6.3-8.6]
Significant difference between males and females *p<.05 6.8Estimate qualified due to high sampling variability; interpret with caution
[4.2-9.5]
11.1
[10.0-12.2]
Significant difference between males and females *p<.05
Hallucinogens (including salvia) 11.0
[9.9-12.1]
14.3
[12.5-16.0]
8.0
[6.7-9.2]
Significant difference between males and females *p<.05 9.3Estimate qualified due to high sampling variability; interpret with caution
[6.2-12.5]
11.3
[10.2-12.5]
 
Ecstasy 3.8
[3.0-4.5]
4.8
[3.6-6.0]
2.8
[1.9-3.6]
Significant difference between males and females *p<.05 8.2Estimate qualified due to high sampling variability; interpret with caution
[5.3-11.1]
2.9
[2.2-3.6]
Significant difference between males and females *p<.05
Salvia 1.4
[0.9-1.8]
1.9Estimate qualified due to high sampling variability; interpret with caution
[1.2-2.6]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.4]
Significant difference between males and females *p<.05 5.4Estimate qualified due to high sampling variability; interpret with caution
[3.0-7.7]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.4-0.9]
Significant difference between males and females *p<.05
Heroin 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.8]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.0]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.6]
 
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 40.2
[38.4-42.0]
46.6
[43.8-49.4]
34.1
[31.8-36.4]
Significant difference between males and females *p<.05 34.5
[28.9-40.0]
41.3
[39.4-40.0]
Significant difference between males and females *p<.05
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 14.0
[12.8-15.2]
17.8
[15.8-19.9]
10.4
[9.0-11.8]
Significant difference between males and females *p<.05 13.0
[9.3-16.8]
14.2
[12.9-15.5]
 
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 40.2
[38.4-42.0]
46.7
[43.9-49.5]
34.1
[31.8-36.4]
Significant difference between males and females *p<.05 34.5
[28.9-40.0]
41.3
[39.5-43.2]
Significant difference between males and females *p<.05
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 14.5
[13.2-15.7]
18.5
[16.4-20.6]
10.7
[9.3-12.1]
Significant difference between males and females *p<.05 15.1
[11.1-19.1]
14.3
[13.1-15.6]
 
Any drugCannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high 40.9
[39.0-42.7]
47.3
[44.5-50.1]
34.8
[32.5-37.2]
Significant difference between males and females *p<.05 35.9
[30.2-41.6]
41.8
[39.9-43.7]
 
Pharmaceutical use past year
Pain Relievers 16.7
[15.4-18.0]
15.8
[14.0-17.7]
17.4
[15.7-19.2]
  14.3
[10.3-18.4]
17.1
[15.8-18.4]
 
Pain Relievers to get high Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Pain Relievers to get high - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of pain relievers (includes to get high) Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.2Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.4]
 
Abuse of pain relievers (includes to get high) - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Stimulants 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.2]
1.2Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.8]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.8]
Significant difference between males and females *p<.05 2.4Estimate qualified due to high sampling variability; interpret with caution
[0.9-3.8]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.4-0.8]
Significant difference between youth age 15-24 and adults age 25+, *p<..05
Stimulants to get high Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Stimulants to get high - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of stimulants (includes to get high) Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Abuse of stimulants (includes to get high) - among users 27.4Estimate qualified due to high sampling variability; interpret with caution
[10.5-44.3]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Sedatives 9.1
[8.1-10.0]
5.9
[4.8-7.1]
12.0
[10.6-13.5]
Significant difference between males and females *p<.05 4.0Estimate qualified due to high sampling variability; interpret with caution
[1.5-6.4]
10.1
[9.0-11.1]
Significant difference between youth age 15-24 and adults age 25+, *p<..05
Sedative to get high Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Sedatives to get high - among users Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability  
Any pharmaceutical 22.9
[21.5-24.4]
20.2
[18.1-22.3]
25.5
[23.5-27.6]
Significant difference between males and females *p<.05 17.6
[13.3-21.9]
23.9
[22.4-25.5]
Significant difference between youth age 15-24 and adults age 25+, *p<..05
Any pharmaceutical to get high 0.3Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.5]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.2Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.3]
 
Any pharmaceutical to get high - among user 1.5Estimate qualified due to high sampling variability; interpret with caution
[0.6-2.4]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.9Estimate qualified due to high sampling variability; interpret with caution
[0.3-1.4]
 
Abuse of any pharmaceutical (includes to get high) 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.1]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.2-1.0]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.7]
 
Abuse of any pharmaceutical (includes to get high) - among users 3.2Estimate qualified due to high sampling variability; interpret with caution
[1.6-4.8]
3.1Estimate qualified due to high sampling variability; interpret with caution
[1.3-4.9]
Estimate suppressed due to high sampling variability   Estimate suppressed due to high sampling variability 1.9Estimate qualified due to high sampling variability; interpret with caution
[1.1-2.8]
 
Drug related harms in past yearTable 1 footnote 3
Any drug harm to self- of total population 1.8
[1.3-2.3]
2.3Estimate qualified due to high sampling variability; interpret with caution
[1.5-3.2]
1.3Estimate qualified due to high sampling variability; interpret with caution
[0.8-1.9]
  5.8Estimate qualified due to high sampling variability; interpret with caution
[3.4-8.1]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.7-1.5]
Significant difference between youth age 15-24 and adults age 25+, *p<..05
Any drug harm to self among users any 5 drugsTable 1 footnote 4 41.6Estimate qualified due to high sampling variability; interpret with caution
[26.9-56.3]
38.2Estimate qualified due to high sampling variability; interpret with caution
[20.7-55.7]
49.7Estimate qualified due to high sampling variability; interpret with caution
[25.6-73.7]
  45.0Estimate qualified due to high sampling variability; interpret with caution
[22.3-67.7]
38.1Estimate qualified due to high sampling variability; interpret with caution
[19.1-57.1]
 
Any drug harm to self among users any drugTable 1 footnote 5 17.6
[13.0-22.1]
16.6Estimate qualified due to high sampling variability; interpret with caution
[10.8-22.4]
19.3Estimate qualified due to high sampling variability; interpret with caution
[11.7-26.9]
  23.1Estimate qualified due to high sampling variability; interpret with caution
[14.0-32.2]
14.2Estimate qualified due to high sampling variability; interpret with caution
[9.3-19.2]
 
 
Table 2: Main 2011 CADUMS indicators by province - Drugs
 
Canada
NL
PE
NS
NB
QC
ON
MB
SK
AB
BC
  •  Sample size
  •  Estimate suppressed due to high sampling variability
  •  Estimate qualified due to high sampling variability; interpret with caution
  •  Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  •  Cocaine/crack, speed, ecstasy, hallucinogens, heroin
  •  Cannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high

Table 2 footnotes

Table 2 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to Table 2 footnote 1 referrer

Table 2 footnote 2

Asked of all users of any illicit drug (cannabis, cocaine, meth/crystal meth, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, abuse of pain killers, abuse of stimulants, sedatives to get high) ; presented among total population

Return to Table 2 footnote 2 referrer

Sample size= 10,076 1,008 1,005 1,006 1,009 1,007 1,009 1,008 1,007 1,008 1,009
Cannabis use
Cannabis - lifetime 39.4 34.8 35.1 43.7 37.4 39.7 37.0 36.1 36.5 43.1 44.3
Cannabis - past year 9.1 10.0 8.9 12.4 9.0 9.0 7.9 10.4 8.8 8.4Estimate qualified due to high sampling variability; interpret with caution 12.1
Illicit drug use past year
Cocaine/Crack 0.9Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Speed 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Methamphetamine/Crystal meth Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Hallucinogens 0.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Ecstasy 0.7Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.3Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Salvia Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Heroin Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 9.4 10.0 9.3 13.3 9.1 9.4 8.0 10.8 8.8 8.7 12.7
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 1.7 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 2.8Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 2.3Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any drugCannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin, pain relievers, stimulant 9.9 10.2 9.8 14.1 9.6 10.0 8.2 10.9 9.3 9.4 13.8
Lifetime Illicit drug use
Cocaine/Crack 6.2 4.4Estimate qualified due to high sampling variability; interpret with caution 3.8Estimate qualified due to high sampling variability; interpret with caution 4.4Estimate qualified due to high sampling variability; interpret with caution 3.7Estimate qualified due to high sampling variability; interpret with caution 8.6 4.7Estimate qualified due to high sampling variability; interpret with caution 5.3Estimate qualified due to high sampling variability; interpret with caution 5.8 5.2Estimate qualified due to high sampling variability; interpret with caution 9.1
Speed 3.4 Estimate suppressed due to high sampling variability 1.9Estimate qualified due to high sampling variability; interpret with caution 1.9Estimate qualified due to high sampling variability; interpret with caution 3.5 6.7 1.8Estimate qualified due to high sampling variability; interpret with caution 2.4Estimate qualified due to high sampling variability; interpret with caution 1.7Estimate qualified due to high sampling variability; interpret with caution 2.9Estimate qualified due to high sampling variability; interpret with caution 4.2Estimate qualified due to high sampling variability; interpret with caution
Methamphetamine/Crystal meth 0.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.4Estimate qualified due to high sampling variability; interpret with caution
Hallucinogens 10.4 8.4 8.4 9.9 8.1 10.0 8.2 10.3 9.2 14.8 15.3
Ecstasy 3.8 3.1Estimate qualified due to high sampling variability; interpret with caution 2.6Estimate qualified due to high sampling variability; interpret with caution 4.3Estimate qualified due to high sampling variability; interpret with caution 3.4Estimate qualified due to high sampling variability; interpret with caution 4.0Estimate qualified due to high sampling variability; interpret with caution 3.2Estimate qualified due to high sampling variability; interpret with caution 3.1Estimate qualified due to high sampling variability; interpret with caution 3.2Estimate qualified due to high sampling variability; interpret with caution 3.8Estimate qualified due to high sampling variability; interpret with caution 5.1Estimate qualified due to high sampling variability; interpret with caution
Salvia 1.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Heroin 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.5Estimate qualified due to high sampling variability; interpret with caution
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 40.2 35.5 36.4 44.5 38.0 40.8 37.4 36.6 37.3 44.0 45.9
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 14.5 10.0 10.1 11.9 10.4 17.0 10.4 11.6 13.2 17.3 18.8
Any drugCannabis, cocaine/crack, meth/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin, pain relievers, stimulant 40.9 35.8 36.7 44.9 38.7 41.6 37.6 37.4 38.0 44.6 47.9
Drug related harms in past yearTable 2 footnote 1
Any drug harm to self - of total populationTable 2 footnote 2 1.8 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 3.9Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 2.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability 1.9Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
 
Table 3: Prevalence of drug use and harms, total population, CAS 2004, CADUMS 2008-2011
 
2004
Overall
2008
Overall
2009
Overall
2010
Overall
2011
Overall

[95% Confidence Interval]

  •  Sample size
  •  Estimate suppressed due to high sampling variability
  •  Estimate qualified due to high sampling variability; interpret with caution
  •  Indicates the difference between 2010 and 2004 is statistically significant.
  •  Indicates the difference between 2011 and 2004 is statistically significant.
  •  Indicates the difference between 2011 and 2010 is statistically significant.
  •  No comparable estimates.
  •  Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  •  Cocaine/crack, speed, ecstasy, hallucinogens, heroin

Table 2 footnotes

Table 3 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to Table 3 footnote 1 referrer

Table 3 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2011: hallucinogens include salvia.

Return to Table 3 footnote 2 referrer

Table 3 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high).

Return to Table 3 footnote 3 referrer

Sample size= 13,909 16,640 13,082 13,615 10,076
Cannabis use
Cannabis - lifetime 44.5
[43.0-46.0]
43.9
[42.4-45.4]
42.4
[40.8-44.1]
41.5
[39.9-43.0]
39.4Indicates the difference between 2011 and 2004 is statistically significant.
[37.6-41.2]
Cannabis - past year 14.1
[13.1-15.1]
11.4
[10.4-12.5]
10.6
[9.5-11.8]
10.7Indicates that the difference between 2010 and 2004 is statistically significant.
[9.8-11.7]
9.1Indicates the difference between 2011 and 2004 is statistically significant.Indicates that the difference between 2011 and 2010 is statistically significant.
[8.0-10.2]
Cannabis - Age of initiation (Years) 18.8
[18.5-19.1]
18.4
[18.2-18.7]
18.7
[18.4-19.0]
18.4
[18.1-18.7]
18.8Indicates that the difference between 2011 and 2010 is statistically significant.
[18.5-19.1]
Illicit drug use past year
Cocaine/Crack 1.9
[1.5-2.3]
1.6
[1.2-2.1]
1.2
[0.8-1.8]
0.7Indicates that the difference between 2010 and 2004 is statistically significant.
[0.5-0.9]
0.9Estimate qualified due to high sampling variability; interpret with cautionIndicates the difference between 2011 and 2004 is statistically significant.
[0.5-1.3]
Speed 0.8
[0.6-1.1]
1.1
[0.8-1.5]
0.4
[0.2-0.8]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.6]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.7]
Hallucinogens (excluding salvia) 0.7
[0.5-0.9]
No comparable estimates 0.7
[0.5-1.1]
0.9
[0.6-1.1]
0.6Estimate qualified due to high sampling variability; interpret with caution
[0.3-0.9]
Hallucinogens (including salvia) No comparable estimates 2.1
[1.7-2.8]
0.9
[0.6-1.4]
1.1
[0.8-1.3]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.2]
Ecstasy 1.1
[0.8-1.5]
1.4
[1.0-1.9]
0.9
[0.6-1.4]
0.7
[0.6-0.9]
0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.0]
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 14.5
[13.5-15.6]
No comparable estimates 11.0
[9.9-12.3]
11.0Indicates that the difference between 2010 and 2004 is statistically significant.
[10.0-12.0]
9.4Indicates the difference between 2011 and 2004 is statistically significant.Indicates that the difference between 2011 and 2010 is statistically significant.
[8.3-10.5]
Any 5 drugs (hallucinogens excl salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 3.0
[2.6-3.6]
No comparable estimates 2.0
[1.5-2.6]
1.8Indicates that the difference between 2010 and 2004 is statistically significant.
[1.5-2.1]
1.7Indicates the difference between 2011 and 2004 is statistically significant.
[1.2-2.2]
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 12.1
[11.1-13.2]
11.1
[10.0-12.3]
11.1
[10.1-12.1]
9.4Indicates that the difference between 2011 and 2010 is statistically significant.
[8.3-10.5]
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 3.9
[3.3-4.7]
2.1
[1.6-2.8]
2.0
[1.6-2.3]
1.9
[1.3-2.4]
Pharmaceutical use past year
Pain Relievers No comparable estimates 21.6
[20.4-22.9]
19.2
[18.0-20.5]
20.6
[19.3-21.8]
16.7Indicates that the difference between 2011 and 2010 is statistically significant.
[15.4-18.0]
Pain Relievers to get high No comparable estimates 0.3
[0.2-0.6]
0.4
[0.2-0.9]
0.2Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.4]
Estimate suppressed due to high sampling variability
Pain Relievers to get high - among users No comparable estimates 1.5
[0.9-2.6]
2.3
[1.1-4.5]
1.1Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.7]
Estimate suppressed due to high sampling variability
Abuse of pain relievers (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Abuse of pain relievers (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Stimulants No comparable estimates 1.1
[0.8-1.5]
1.0
[0.7-1.4]
1.0
[0.8-1.3]
0.9Estimate qualified due to high sampling variability; interpret with caution
[0.6-1.2]
Stimulants to get high No comparable estimates 0.3
[0.1-0.6]
0.1
[0.0-0.3]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Stimulants to get high - among users No comparable estimates 25.5
[12.3-45.5]
9.4
[2.6-28.6]
Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates 27.4Estimate qualified due to high sampling variability; interpret with caution
[10.5-44.3]
Sedatives No comparable estimates 10.7
[9.8-11.6]
9.1
[8.2-10.0]
8.7
[7.8-9.6]
9.1
[8.1-10.0]
Sedatives to get high No comparable estimates 0.2
[0.0-0.5]
0.2
[0.1-0.4]
0.05Estimate qualified due to high sampling variability; interpret with caution
[0.02-0.08]
Estimate suppressed due to high sampling variability
Sedatives to get high - among users No comparable estimates 1.4Estimate qualified due to high sampling variability; interpret with caution
[0.5-4.3]
1.7
[0.6-4.7]
0.5Estimate qualified due to high sampling variability; interpret with caution
[0.2-0.9]
Estimate suppressed due to high sampling variability
Any pharmaceutical No comparable estimates 28.4
[27.0-29.7]
25.0
[23.7-26.4]
26.0
[24.6-27.3]
22.9Indicates that the difference between 2011 and 2010 is statistically significant.
[21.5-24.4]
Any pharmaceutical to get high No comparable estimates 0.6
[0.3-0.9]
0.6
[0.3-1.0]
0.3Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.4]
0.3Estimate qualified due to high sampling variability; interpret with caution
[0.1-0.5]
Any pharmaceutical to get high - among users No comparable estimates 2.0
[1.2-3.2]
2.3
[1.2-4.1]
1.0Estimate qualified due to high sampling variability; interpret with caution
[0.5-1.6]
1.5Estimate qualified due to high sampling variability; interpret with caution
[0.6-2.4]
Abuse of any pharmaceutical (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates 0.7Estimate qualified due to high sampling variability; interpret with caution
[0.4-1.1]
Abuse of any pharmaceutical (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates 3.2Estimate qualified due to high sampling variability; interpret with caution
[1.6-4.8]
Drug related harms in past yearTable 3 footnote 1
Any drug harm to self- of total population 2.8
[2.4-3.3]
2.7
[2.1-3.3]
No comparable estimates 2.1
[1.7-2.6]
1.8Indicates the difference between 2011 and 2004 is statistically significant.
[1.3-2.3]
Any drug harm to self among users any 5 drugsTable 3 footnote 2 36.7
[29.1-45.1]
37.5
[28.9-47.0]
No comparable estimates 36.4
[27.7-45.0]
41.6Estimate qualified due to high sampling variability; interpret with caution
[26.9-56.3]
Any drug harm to self among users any drugTable 3 footnote 3 17.5
[14.8-20.5]
21.7
[17.6-26.3]
No comparable estimates 17.0
[13.5-20.5]
17.6
[13.0-22.1]
 
Table 4: Prevalence of drug use and harms, by age group, CAS 2004, CADUMS 2008-2011
 
CAS 04
15-24
CADUMS 08
15-24
CADUMS 09
15-24
CADUMS 10
15-24
CADUMS 11
15-24
CAS 04
25+
CADUMS 08
25+
CADUMS 09
25+
CADUMS 10
25+
CADUMS 11
25+
  •  Sample size
  •  Estimate suppressed due to high sampling variability
  •  Estimate qualified due to high sampling variability; interpret with caution
  •  Indicates the difference between 2010 and 2004 is statistically significant.
  •  Indicates the difference between 2011 and 2004 is statistically significant.
  •  Indicates the difference between 2011 and 2010 is statistically significant.
  •  No comparable estimates.
  •  Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  •  Cocaine/crack, speed, ecstasy, hallucinogens, heroin

Table 4 footnotes

Table 4 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to Table 4 footnote 1 referrer

Table 4 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2011: hallucinogens include salvia.

Return to Table 4 footnote 2 referrer

Table 4 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high).

Return to Table 4 footnote 3 referrer

Sample size= 2,085 1,443 955 3,989 671 11, 519 15,197 12,079 9,626 9,405
Cannabis use
Cannabis - lifetime 61.4 52.9 42.9 41.7Indicates that the difference between 2010 and 2004 is statistically significant. 34.0Indicates the difference between 2011 and 2004 is statistically significant.Indicates that the difference between 2011 and 2010 is statistically significant.
41.8 42.1 42.3 41.4 40.4
Cannabis - past year 37.0 32.7 26.3 25.1Indicates that the difference between 2010 and 2004 is statistically significant. 21.6Indicates the difference between 2011 and 2004 is statistically significant.
10.0 7.3 7.6 7.9 6.7Indicates the difference between 2011 and 2004 is statistically significant.
Age of initiation (Years) 15.6 15.5 15.6 15.7 15.6
19.7 19.2 19.3 18.9Indicates that the difference between 2010 and 2004 is statistically significant. 19.3
Illicit drug use past year
Cocaine/Crack 5.5 5.9 3.0Estimate qualified due to high sampling variability; interpret with caution 2.7Indicates that the difference between 2010 and 2004 is statistically significant. Estimate suppressed due to high sampling variability 1.2 0.8 0.9 0.3QIndicates that the difference between 2010 and 2004 is statistically significant. 0.7Estimate qualified due to high sampling variability; interpret with caution
Speed 3.9 3.7 Estimate suppressed due to high sampling variability 1.9QIndicates that the difference between 2010 and 2004 is statistically significant. Estimate suppressed due to high sampling variability 0.2 0.6 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Hallucinogens (excl. salvia) 3.5 No comparable estimates 3.2Estimate qualified due to high sampling variability; interpret with caution 3.4 2.0Estimate qualified due to high sampling variability; interpret with caution 0.1 No comparable estimates 0.3 0.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability
Hallucinogens (incl. salvia) No comparable estimates 10.2 4.4 4.6 3.4Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 0.6 0.3 0.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability
Ecstasy 4.4 6.5 3.6 3.8 2.6Estimate qualified due to high sampling variability; interpret with caution 0.5 0.4 0.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 37.9 No comparable estimates 27.3 25.9Indicates that the difference between 2010 and 2004 is statistically significant. 21.9Indicates the difference between 2011 and 2004 is statistically significant. 10.3 No comparable estimates 7.9 8.1Indicates that the difference between 2010 and 2004 is statistically significant. 6.9Indicates the difference between 2011 and 2004 is statistically significant.
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 11.3 No comparable estimates 5.5 7.0Indicates that the difference between 2010 and 2004 is statistically significant. 4.8Estimate qualified due to high sampling variability; interpret with cautionIndicates the difference between 2011 and 2004 is statistically significant. 1.5 No comparable estimates 1.3 0.8Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 34.0 27.5 26.1 21.9 No comparable estimates 7.9 7.9 8.2 6.9
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 15.4 6.3 7.9 5.8Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 1.7 1.3 0.8Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution
Pharmaceutical Use past year
Pain Relievers No comparable estimates 17.7 14.6 18.2 14.3 No comparable estimates 22.4 20.2 21.0 17.1Indicates that the difference between 2011 and 2010 is statistically significant.
Pain Relievers to get high No comparable estimates 0.9Estimate qualified due to high sampling variability; interpret with caution 1.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.2 0.3 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Pain Relievers to get high - among users No comparable estimates 4.9 8.5 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 1.0 1.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of pain relievers (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates 0.2Estimate qualified due to high sampling variability; interpret with caution
Abuse of pain relievers (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Stimulants No comparable estimates 3.1 2.7Estimate qualified due to high sampling variability; interpret with caution 3.2 2.4Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 0.7 0.6 0.6Estimate qualified due to high sampling variability; interpret with caution 0.6Estimate qualified due to high sampling variability; interpret with caution
Stimulants to get high No comparable estimates 1.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.1 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Stimulants to get high - among users No comparable estimates 38.3Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 14.7Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Sedatives No comparable estimates 5.5 4.0 3.5 4.0Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 11.7 10.1 9.7 10.1
Sedative to get high No comparable estimates 0.8Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Sedatives to get high - among users No comparable estimates 14.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any pharmaceutical No comparable estimates 22.3 18.2 22.1 17.6 No comparable estimates 29.5 26.3 26.7 23.9Indicates that the difference between 2011 and 2010 is statistically significant.
Any pharmaceutical to get high No comparable estimates 2.1Estimate qualified due to high sampling variability; interpret with caution 1.7Estimate qualified due to high sampling variability; interpret with caution 0.8Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability No comparable estimates 0.3 0.3 Estimate suppressed due to high sampling variability 0.2Estimate qualified due to high sampling variability; interpret with caution
Any pharmaceutical to get high - among users No comparable estimates 9.4 9.5 3.8 Estimate suppressed due to high sampling variability No comparable estimates 0.9 1.3 Estimate suppressed due to high sampling variability 0.9Estimate qualified due to high sampling variability; interpret with caution
Abuse of any pharmaceutical (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates 0.5Estimate qualified due to high sampling variability; interpret with caution
Abuse of any pharmaceutical (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates 1.9Estimate qualified due to high sampling variability; interpret with caution
Drug related harms in past yearTable 4 footnote 1
Any drug harm to self - of total population 9.5 10.8 No comparable estimates 6.9 5.8Estimate qualified due to high sampling variability; interpret with caution 1.6 1.1 No comparable estimates 1.2Estimate qualified due to high sampling variability; interpret with caution 1.1Estimate qualified due to high sampling variability; interpret with caution
Any drug harm to self among users any 5 drugsTable 4 footnote 2 42.1 42.0 No comparable estimates 41.6 45.0Estimate qualified due to high sampling variability; interpret with caution 28.7 29.5 No comparable estimates 26.6Estimate qualified due to high sampling variability; interpret with caution 38.1Estimate qualified due to high sampling variability; interpret with caution
Any drug harm to self among users any drugTable 4 footnote 3 24.0 31.5 No comparable estimates 24.7 23.1Estimate qualified due to high sampling variability; interpret with caution 12.7 13.5 No comparable estimates 12.2Estimate qualified due to high sampling variability; interpret with caution 14.2Estimate qualified due to high sampling variability; interpret with caution
 
Table 5: Prevalence of drug use and harms, by sex, CAS 2004, CADUMS 2008-2011
 
CAS 04
Males
CADUMS 08
Males
CADUMS 09
Males
CADUMS 10
Males
CADUMS 11
Males
CAS 04
Females
CADUMS 08
Females
CADUMS 09
Females
CADUMS 10
Females
CADUMS 11
Females
  •  Sample size
  •  Estimate suppressed due to high sampling variability
  •  Estimate qualified due to high sampling variability; interpret with caution
  •  Indicates the difference between 2010 and 2004 is statistically significant.
  •  Indicates the difference between 2010 and 2009 is statistically significant.
  •  Indicates the difference between 2011 and 2004 is statistically significant.
  •  Indicates the difference between 2011 and 2010 is statistically significant.
  •  No comparable estimates.
  •  Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin
  •  Cocaine/crack, speed, ecstasy, hallucinogens, heroin

Table 5 footnotes

Table 5 footnote 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to Table 5 footnote 1 referrer

Table 5 footnote 2

Among past year users any 5 drugs (cocaine, speed, hallucinogens, ecstasy, heroin). CADUMS 2010-2011: hallucinogens include salvia.

Return to Table 5 footnote 2 referrer

Table 5 footnote 3

Among past year users CAS (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, steroids), CADUMS 2008 (cannabis, cocaine, speed, hallucinogens, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2010 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, pain killers to get high, stimulants to get high, sedatives to get high), CADUMS 2011 (cannabis, cocaine, speed, hallucinogens including salvia, ecstasy, inhalants, heroin, meth, abuse of pain killers, abuse of stimulants, sedatives to get high).

Return to Table 5 footnote 3 referrer

Sample size= 5,721 6,583 5,260 5,980 4,247 8,188 10,057 7,822 7,635 5,829
Cannabis use
Cannabis - lifetime 50.1 49.3 48.0 48.8 45.5 39.2 38.8 37.2 34.5Indicates that the difference between 2010 and 2004 is statistically significant. 33.6Indicates the difference between 2011 and 2004 is statistically significant.
Cannabis - past year 18.2 14.4 14.2 14.6Indicates that the difference between 2010 and 2004 is statistically significant. 12.2Indicates the difference between 2011 and 2004 is statistically significant. 10.2 8.6 7.2 7.1Indicates that the difference between 2010 and 2004 is statistically significant. 6.2Indicates the difference between 2011 and 2004 is statistically significant.
Cannabis - Age of initiation (Years) 18.8 18.5 18.7 18.4 18.6 18.7 18.4 18.7 18.4 19.0Indicates that the difference between 2011 and 2010 is statistically significant.
Illicit drug use past year
Cocaine/Crack 2.7 2.3 1.5 1.0QIndicates that the difference between 2010 and 2004 is statistically significant. 1.4Estimate qualified due to high sampling variability; interpret with caution 1.1 0.9 0.9 0.4QIndicates that the difference between 2010 and 2004 is statistically significant. Estimate suppressed due to high sampling variability
Speed 1.0 1.3 Estimate suppressed due to high sampling variability 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability 0.7 0.8 Estimate suppressed due to high sampling variability 0.4Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability
Hallucinogens (excl. salvia) 1.0 No comparable estimates 0.7 1.3Estimate qualified due to high sampling variability; interpret with caution 0.9Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability No comparable estimates 0.8 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability
Hallucinogens (incl. salvia) No comparable estimates 3.3 1.1 1.6 1.3Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 1.1 0.8 0.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability
Ecstasy 1.5 1.7 1.1 0.9Estimate qualified due to high sampling variability; interpret with caution 0.9Estimate qualified due to high sampling variability; interpret with caution 0.7 1.1 0.7 0.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability
Any 6 drugs (hallucinogens excl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin 18.7 No comparable estimates 14.7 15.0Indicates that the difference between 2010 and 2004 is statistically significant. 12.4Indicates the difference between 2011 and 2004 is statistically significant.Indicates that the difference between 2011 and 2010 is statistically significant. 10.6 No comparable estimates 7.6 7.3Indicates that the difference between 2010 and 2004 is statistically significant. 6.5Indicates the difference between 2011 and 2004 is statistically significant.
Any 5 drugs (hallucinogens excl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin 4.3 No comparable estimates 2.5 2.5Indicates that the difference between 2010 and 2004 is statistically significant. 2.4Estimate qualified due to high sampling variability; interpret with cautionIndicates the difference between 2011 and 2004 is statistically significant. 1.8 No comparable estimates 1.5 1.2 1.0Estimate qualified due to high sampling variability; interpret with caution
Any 6 drugs (hallucinogens incl. salvia)Cannabis, cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 15.3 14.8 15.1 12.5Indicates that the difference between 2011 and 2010 is statistically significant. No comparable estimates 9.1 7.6 7.3 6.5
Any 5 drugs (hallucinogens incl. salvia)Cocaine/crack, speed, ecstasy, hallucinogens, heroin No comparable estimates 5.5 2.8 2.8 2.7Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 2.4 1.5 1.3 1.1Estimate qualified due to high sampling variability; interpret with caution
Pharmaceutical Use past year
Pain Relievers No comparable estimates 18.9 18.3 20.9 15.8Indicates that the difference between 2011 and 2010 is statistically significant. No comparable estimates 24.2 20.2 20.3 17.4Indicates that the difference between 2011 and 2010 is statistically significant.
Pain Relievers to get high No comparable estimates 0.3Estimate qualified due to high sampling variability; interpret with caution 0.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.4Estimate qualified due to high sampling variability; interpret with caution 0.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Pain Relievers to get high - among users No comparable estimates 1.5 2.8 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 1.5 1.8 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of pain relievers (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of pain relievers (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Stimulants No comparable estimates 1.0 0.6 1.2Estimate qualified due to high sampling variability; interpret with cautionIndicates that the difference between 2010 and 2009 is statistically significant. 1.2Estimate qualified due to high sampling variability; interpret with caution No comparable estimates 1.2 1.2 0.9 0.5Estimate qualified due to high sampling variability; interpret with caution
Stimulants to get high No comparable estimates 0.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.3Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Stimulants to get high - among users No comparable estimates 22.5Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 27.8Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Abuse of stimulants (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Sedatives No comparable estimates 8.0 7.0 6.4 5.9 No comparable estimates 13.2 11.1 10.8 12.0
Sedatives to get high No comparable estimates 0.1Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.2Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Sedatives to get high - among users No comparable estimates Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 1.6Estimate qualified due to high sampling variability; interpret with caution Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any pharmaceutical No comparable estimates 24.4 22.3 24.7 20.2Indicates that the difference between 2011 and 2010 is statistically significant. No comparable estimates 32.1 27.6 27.1 25.5
Any pharmaceutical to get high No comparable estimates 0.5Estimate qualified due to high sampling variability; interpret with caution 0.7 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 0.6 0.4 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Any pharmaceutical to get high - among users No comparable estimates 2.1 3.3 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability No comparable estimates 1.9 1.5 Estimate suppressed due to high sampling variability Estimate suppressed due to high sampling variability
Abuse of any pharmaceutical (includes to get high) No comparable estimates No comparable estimates No comparable estimates No comparable estimates 0.6Estimate qualified due to high sampling variability; interpret with caution No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Abuse of any pharmaceutical (includes to get high) - among users No comparable estimates No comparable estimates No comparable estimates No comparable estimates 3.1Estimate qualified due to high sampling variability; interpret with caution No comparable estimates No comparable estimates No comparable estimates No comparable estimates Estimate suppressed due to high sampling variability
Drug related harms in past yearTable 5 footnote 1
Any drug harm to self - of total population 3.8 3.5 No comparable estimates 2.7 2.3Estimate qualified due to high sampling variability; interpret with caution 1.9 1.8 No comparable estimates 1.7 1.3Estimate qualified due to high sampling variability; interpret with caution
Any drug harm to self among users any 5 drugsTable 5 footnote 2 37.2 36.1 No comparable estimates 35.8 38.2Estimate qualified due to high sampling variability; interpret with caution 35.7 40.7 No comparable estimates 37.5Estimate qualified due to high sampling variability; interpret with caution 49.7Estimate qualified due to high sampling variability; interpret with caution
Any drug harm to self among users any drugTable 5 footnote 3 18.4 22.8 No comparable estimates 15.8 16.6Estimate qualified due to high sampling variability; interpret with caution 16.0 19.8 No comparable estimates 19.2 19.3Estimate qualified due to high sampling variability; interpret with caution
 
Table 6: Main 2011 CADUMS indicators by sex and by age - Alcohol
 
Overall
Males
Females
15-24
25+
  •  Sample size

[95% Confidence Interval]

Table 6 footnotes

Table 6 footnote 1

Significant difference between males and females

Return to table 6 footnote 1 referrer

Table 6 footnote 2

Significant difference between youth age 15-24 and adults age 25+

Return to table 6 footnote 2 referrer

Table 6 footnote 3

Based on alcohol consumption in the previous 7 days

Return to table 6 footnote 3 referrer

Sample size= 10,076 4,247 5,829   671 9,405  
Alcohol
Lifetime Use 89.7
[88.4-91.0]
92.9
[91.3-94.5]
86.8
[84.7-88.8]
Significant difference between males and females 77.9
[72.4-83.4]
92.0
[91.0-93.1]
Significant difference between youth age 15-24 and adults age 25+
Past 12 month Use 78.0
[76.4-79.5]
81.9
[79.6-84.1]
74.3
[72.0-76.5]
Significant difference between males and females 70.8
[65.1-76.6]
79.3
[77.8-80.9]
Significant difference between youth age 15-24 and adults age 25+
Past 30 days Use 63.1
[61.2-64.9]
69.5
[66.8-72.1]
57.0
[54.5-59.5]
Significant difference between males and females 51.9
[45.8-58.1]
65.2
[63.4-67.0]
Significant difference between youth age 15-24 and adults age 25+
Age of initiation (years) 18.1
[18.0-18.3]
17.5
[17.3-17.7]
18.8
[18.5-19.1]
Significant difference between males and females 16.0
[15.7-16.2]
18.5
[18.3-18.7]
Significant difference between youth age 15-24 and adults age 25+
Exceeding low-risk drinking guidelinesTable 6 footnote 3
Exceeds LRDG chronic 14.4
[13.1-15.8]
18.1
[15.9-20.3]
11.1
[9.5-12.6]
Significant difference between males and females 14.9
[10.6-19.2]
14.4
[13.0-15.7]
 
Exceeds LRDG acute 10.1
[8.9-11.2]
13.5
[11.5-15.4]
7.0
[5.6-8.3]
Significant difference between males and females 12.8
[8.7-16.9]
9.5
[8.4-10.7]
 
Exceeds LRDG chronic - among drinkers 18.7
[17.0-20.4]
22.3
[19.7-25.0]
15.0
[13.0-17.1]
Significant difference between males and females 21.1
[15.2-26.9]
18.3
[16.6-20.0]
 
Exceeds LRDG acute - among drinkers 13.1
[11.6-14.5]
16.6
[14.3-19.0]
9.5
[7.7-11.2]
Significant difference between males and females 18.1
[12.5-23.7]
12.2
[10.7-13.6]
Significant difference between youth age 15-24 and adults age 25+
 
Table 7: Main 2011 CADUMS indicators by province - Alcohol
 
Canada
NL
PE
NS
NB
QC
ON
MB
SK
AB
BC
  •  Sample size

Table 7 footnotes

Table 7 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 7 footnote 1 referrer

Sample size= 10,076 1,008 1,005 1,006 1,009 1,007 1,009 1,008 1,007 1,008 1,009
Alcohol
Lifetime Use 89.7 90.2 89.1 90.3 90.1 92.8 86.6 90.4 93.2 91.7 90.6
Past 12 month Use 78.0 75.2 72.7 73.8 73.3 81.7 76.1 77.8 77.6 80.0 77.1
Past 30 days Use 63.1 55.8 58.2 55.4 56.4 68.7 62.4 61.1 61.2 64.8 58.2
Exceeding low-risk drinking guidelinesTable 7 footnote 1
Exceeds LRDG chronic 14.4 17.0 13.8 16.3 15.4 17.4 12.9 14.7 12.3 15.8 12.1
Exceeds LRDG acute 10.1 13.1 11.1 11.4 11.4 11.2 9.7 11.1 10.4 11.3 7.1
Exceeds LRDG chronic - among drinkers 18.7 22.8 19.2 22.4 21.2 21.4 17.1 19.1 16.0 19.9 15.9
Exceeds LRDG acute - among drinkers 13.1 17.6 15.5 15.7 15.8 13.7 12.8 14.4 13.5 14.2 9.3
 
Table 8: Prevalence of alcohol use and exceeding LRDG, total population, CAS 2004, CADUMS 2008 - 2011
 
2004
Overall
2008
Overall
2009
Overall
2010
Overall
2011
Overall

[95% Confidence Interval]

  •  Sample size
  •  Indicates the difference between 2010 and 2004 is statistically significant.
  •  Indicates the difference between 2011 and 2004 is statistically significant.

Table 8 footnotes

Table 8 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 8 footnote 1 referrer

Sample size= 13,909 16,640 13,082 13,615 10,076
Alcohol
Lifetime Use 92.8
[91.6-93.9]
90.2
[89.2-91.1]
88.6
[87.5-89.6]
88.9Indicates the difference between 2010 and 2004 is statistically significant.
[87.9-89.9]
89.7Indicates the difference between 2011 and 2004 is statistically significant.
[88.4-91.0]
Past 12 month Use 79.3
[78.1-80.5]
77.3
[76.0-78.6]
76.5
[75.1-77.8]
77.0Indicates the difference between 2010 and 2004 is statistically significant.
[75.6-78.3]
78.0
[76.4-79.5]
Age of Initiation (Years) 17.9
[17.8-18.1]
18.0
[17.9-18.2]
18.0
[17.9-18.2]
18.2
[18.0-18.3]
18.1
[18.0-18.3]
Exceeding low-risk drinking guidelinesTable 8 footnote 1
Exceeds LRDG chronic 14.3
[13.2-15.3]
15.0
[13.9-16.2]
14.5
[13.3-15.7]
14.5
[13.4-15.6]
14.4
[13.1-15.8]
Exceeds LRDG acute 10.2
[9.2-11.1]
10.9
[9.8-11.9]
11.7
[10.5-12.9]
10.5
[9.5-11.5]
10.1
[8.9-11.2]
Exceeds LRDG chronic - among drinkers 18.0
[16.7-19.4]
19.8
[18.3-21.2]
19.1
[17.6-20.7]
19.1
[17.6-20.5]
18.7
[17.0-20.4]
Exceeds LRDG acute - among drinkers 12.9
[11.7-14.0]
14.3
[12.9-15.6]
15.5
[14.0-17.0]
13.8
[12.6-15.1]
13.1
[11.6-14.5]
 
Table 9: Prevalence of alcohol use and exceeding LRDG, by age, CAS 2004, CADUMS 2008 - 2011
 
CAS 04
15-24
CADUMS 08
15-24
CADUMS 09
15-24
CADUMS 10
15-24
CADUMS 11
15-24
CAS 04
25+
CADUMS 08
25+
CADUMS 09
25+
CADUMS 10
25+
CADUMS 11
25+
  •  Sample size
  •  Indicates the difference between 2011 and 2004 is statistically significant.

Table 9 footnotes

Table 9 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 9 footnote 1 referrer

Sample size= 2,085 1,443 955 3,989 671 11,519 15,197 12,079 9,626 9,405
Alcohol
Lifetime Use 90.0 83.5 81.8 79.0 77.9Indicates the difference between 2011 and 2004 is statistically significant. 93.6 91.4 89.9 90.9 92.0
Past 12 month Use 82.9 78.4 75.5 71.5 70.8Indicates the difference between 2011 and 2004 is statistically significant. 78.8 77.1 76.7 78.0 79.3
Age of Initiation (Years) 15.6 15.6 15.9 15.9 16.0 18.3 18.5 18.4 18.6 18.5
Exceeding low-risk drinking guidelinesTable 9 footnote 1
Exceeds LRDG chronic 18.6 22.8 19.8 18.4 14.9 9.8 13.6 13.4 13.8 14.4
Exceeds LRDG acute 13.7 18.4 17.4 15.1 12.8 6.4 9.4 10.6 9.6 9.5
Exceeds LRDG chronic - among drinkers 22.4 29.5 26.4 25.9 21.1 13.0 17.9 17.7 17.8 18.3
Exceeds LRDG acute - among drinkers 16.5 23.8 23.2 21.3 18.1 18.1 12.4 13.9 12.5 12.2
 
Table 10: Prevalence of alcohol use and exceeding LRDG, by sex, CAS 2004, CADUMS 2008 - 2011
 
CAS 04
Males
CADUMS 08
Males
CADUMS 09
Males
CADUMS 10
Males
CADUMS 11
Males
CAS 04
Females
CADUMS 08
Females
CADUMS 09
Females
CADUMS 10
Females
CADUMS 11
Females
  •  Sample size
  •  Indicates the difference between 2010 and 2004 is statistically significant.
  •  Indicates the difference between 2011 and 2004 is statistically significant.
  •  Indicates the difference between 2010 and 2009 is statistically significant.

Table 10 footnotes

Table 10 footnote 1

Based on alcohol consumption in the previous 7 days

Return to table 10 footnote 1 referrer

Sample size= 5,721 6,583 5,260 5,980 4,247 8,188 10,057 7,822 7,635 5,829
Alcohol
Lifetime Use 94.6 93.0 91.0Indicates the difference between 2010 and 2004 is statistically significant. 91.3Indicates the difference between 2010 and 2004 is statistically significant. 92.9 91.1 87.5Indicates the difference between 2010 and 2009 is statistically significant . 86.3Indicates the difference between 2010 and 2004 is statistically significant. 86.7Indicates the difference between 2010 and 2004 is statistically significant. 86.8Indicates the difference between 2011 and 2004 is statistically significant.
Past 12 month Use 82.0 81.4 80.2 80.2 81.9 76.8 73.5 73.0Indicates the difference between 2010 and 2004 is statistically significant. 73.9 74.3
Age of Initiation (Years) 17.1 17.4 17.3 17.5 17.5 18.7 18.6 18.7 18.8 18.8
Exceeding low-risk drinking guidelinesTable 10 footnote 1
Exceeds LRDG chronic 17.2 18.9 17.6 17.2 18.1 11.5 11.6 11.6 12.1 11.1
Exceeds LRDG acute 13.0 14.8 15.2 13.6 13.5 7.5 7.4 8.5 7.7 7.0
Exceeds LRDG chronic - among drinkers 21.1 23.6 22.2 21.6 22.3 15.0 16.0 22.2 16.4 15.0
Exceeds LRDG acute - among drinkers 15.9 18.5 19.1 17.1 16.6 9.8 10.1 11.8 10.5 9.5

Back to main page